CSF3 and myocardial infarction: Thus, a number of cell-mobilizing agents, such as granulocyte colony-stimulating factor (G-CSF), have been used to increase the number of circulating stem cells in patients with myocardial infarction, but the results have been inconsistent, and meta-analyses found little evidence of benefit [14].